Multi‐Organelle Stress‐Induced Paraptosis by a ROS‐Amplifying Nanocatalyst for Enhanced Cancer Immunotherapy

Read full text
Authors: Zhe Yu, Haozhe Ren, Hua Li, Jinghan Zhao, Miaomiao Cao, Tian Tang, Youbei Qiao, Liting Chen, Tiehong Yang, Wu Hz
Cited by: 3
References: 58

Abstract

ABSTRACT Chemodynamic therapy (CDT) is severely limited by inadequate intracellular H 2 O 2 and frequent apoptosis resistance. Herein, a porous Fe 3 O 4 nanoplatform is engineered through coating of Fe 3 + ‐tannic acid complex onto nanoclusters simultaneously loaded with carbonyl cyanide 3‐chlorophenylhydrazone (CCCP, a mitochondrial uncoupler) and lactate oxidase (LOD). By self‐supplying H 2 O 2 and concurrently blocking autophagic flux, this system is engineered to potentiate CDT efficacy. Beyond the expected therapeutic outcome, we uncover that this nanoplatform triggers an unconventional cell death pathway—paraptosis. Acid‐triggered dissociation in the tumor microenvironment releases Fe 2 + /Fe 3 + for Fenton reactions while LOD simultaneously converts lactate to H 2 O 2 , overcoming the H 2 O 2 bottleneck. CCCP further synergizes this process by collapsing the mitochondrial membrane potential, which amplifies ROS leakage and culminates in an oxidative storm. This dramatic surge in ROS directly induces mitochondrial dysfunction and initiates endoplasmic reticulum stress, while also suppressing autophagic flux. Collectively, these multi‐organelle stresses markedly exacerbate intracellular damage and lead to paraptotic cell death, characterized by extensive cytoplasmic vacuolization, eliciting robust immunogenic cell death. Combined with αPD‐L1, the nanoplatform potently activates antitumor immunity and suppresses both primary and distant tumors. This work pioneers a paraptosis activation strategy driven by an iron‐based nanodrug, redefining CDT efficacy through multi‐organelle stress synergy for amplified immunotherapy.

Fields of Study & Subjects

Nanoplatforms for cancer theranostics Advanced Nanomaterials in Catalysis Nanoparticle-Based Drug Delivery

Publication details

Journal / source
Advanced Science
Publisher
Wiley
Volume
13
Issue
26
Pages
e20031–e20031
Publication date
5 March 2026
Language
EN